NBP

$0.88013.08%-0.028

Novabridge Biosciences Adr (NBP)

Novabridge Biosciences Adr Stock (NBP) Forecast

The Novabridge Biosciences Adr (NBP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.4425, representing a -49.72% decrease from the current price of $0.8801. The highest analyst price target is $0.8159, and the lowest is $0.0691.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month NBP Price Target

Average 0.9125 (+3.69% Downside)

Is Novabridge Biosciences Adr (NBP) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	22.31	Buy
STOCH(9,6)	3.74	Buy
STOCHRSI(14)	6.54	Buy
MACD(12,26)	-0.13	Sell
ADX(14)	35.24	Sell
William %R	-97.37	Buy
CCI(14)	-159.07	Sell

Buy: 4 · Sell: 3 · Neutral: 0Summary: Buy

Moving Averages

Period	Simple	Exponential
MA10	1.10 Sell	1.08 Sell
MA20	1.21 Sell	1.18 Sell
MA50	1.42 Sell	1.38 Sell
MA100	1.61 Sell	1.63 Sell
MA200	2.11 Sell	2.24 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, NBP could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 13 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on NBP, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 22.31 indicates that NBP is oversold. This indicates that NBP price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
STOCH (Stochastic Oscillator): The STOCH value of 3.74 indicates that NBP is oversold. This indicates that NBP price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 6.54 indicates that NBP is oversold. This suggests that NBP price is at or near the lowest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 35.24 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -159.07 indicates that NBP is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.

Long-term NBP price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Novabridge Biosciences Adr financial reports and earnings history, Novabridge Biosciences Adr (NBP) stock could reach $10.93 by 2030, $46.20 by 2040 and $69.31 by 2050. See the projected annual prices until 2050 of the Novabridge Biosciences Adr stock below:

Novabridge Biosciences Adr (NBP) is expected to reach an average price of $6.32 in 2035, with a high prediction of $25.25 and a low estimate of $6.43. This indicates an +617.62% change from the last recorded price of $0.8801.
Novabridge Biosciences Adr (NBP) stock is projected to chart a bullish course in 2040, with an average price target of $35.71, representing an +3,957% change from its current level. The forecast ranges from a conservative $9.26 to a sky-high $46.20.
Our analysts predict Novabridge Biosciences Adr (NBP) to change +3,452% by 2045, soaring from $12.69 to an average price of $31.26, potentially reaching $61.96. While $12.69 is the low estimate, the potential upside is significant.
Novabridge Biosciences Adr (NBP) stock is expected to climb by 2050, reaching an average of $16.97, a +1,828% change from its current level. However, a wide range of estimates exists, with high and low targets of $69.31 and $16.97, respectively, highlighting the market's uncertainty.

Novabridge Biosciences Adr Stock (NBP) Year by Year Forecast

Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2026

The predicted value for Novabridge Biosciences Adr (NBP) in 2026 is set at an average of $1.86. Estimates vary from a peak of $5.19 to a trough of $0.0577, indicating an +111.65% surge from the present price of $0.8801.

Month	Average	Low	High	Change from today's price
December, 2026	$0.6159	$0.0691	$0.8159	-30.02%

Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Novabridge Biosciences Adr (NBP) is $0.2684, with a high forecast of $1.82 and a low forecast of $0.000144. This indicates an -69.50% decrease from the last price of $0.8801.

Month	Average	Low	High	Change from today's price
January, 2027	$0.3349	$0.2649	$1.82	-61.94%
February, 2027	$0.544	$0.0418	$0.8668	-38.19%
March, 2027	$0.0646	$0.000144	$0.9131	-92.66%
April, 2027	$0.2556	$0.3124	$0.2976	-70.96%
May, 2027	$0.0442	$0.0692	$0.199	-94.97%
June, 2027	$0.3752	$0.252	$0.4374	-57.37%
July, 2027	$0.3661	$0.5361	$0.436	-58.40%
August, 2027	$0.0253	$0.0415	$0.4107	-97.13%
September, 2027	$0.4643	$0.0552	$0.4843	-47.24%
October, 2027	$0.2634	$0.2534	$0.5266	-70.07%
November, 2027	$0.3297	$0.0929	$0.4179	-62.53%
December, 2027	$0.1538	$0.1538	$0.4993	-82.52%

Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2028

In 2028, Novabridge Biosciences Adr (NBP) is projected to reach an average price of $2.44, with a high projection of $3.26 and a low estimate of $0.9837. This indicates an +177.36% rise from the last price of $0.8801.

Month	Average	Low	High	Change from today's price
January, 2028	$3.62	$3.43	$3.26	+311.53%
February, 2028	$2.70	$2.90	$3.18	+207.21%
March, 2028	$2.90	$2.68	$2.69	+229.00%
April, 2028	$3.00	$2.81	$2.57	+240.58%
May, 2028	$3.12	$2.83	$2.75	+255.04%
June, 2028	$2.91	$3.00	$2.90	+230.26%
July, 2028	$2.54	$2.49	$2.38	+189.05%
August, 2028	$2.68	$2.65	$2.70	+204.60%
September, 2028	$1.96	$2.22	$2.55	+122.43%
October, 2028	$1.78	$1.79	$1.63	+102.81%
November, 2028	$1.13	$1.18	$1.51	+28.03%
December, 2028	$0.9487	$0.9837	$0.9973	+7.79%

Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2029

The 2029 price forecast for Novabridge Biosciences Adr Stock (NBP) is $5.04 on average, with a high prediction of $7.10 and a low estimate of $0.6664. This represents an +473.23% increase from the previous price of $0.8801.

Month	Average	Low	High	Change from today's price
January, 2029	$0.766	$0.766	$0.9296	-12.97%
February, 2029	$6.87	$0.6664	$6.80	+680.59%
March, 2029	$7.35	$7.37	$7.10	+735.45%
April, 2029	$6.43	$6.43	$6.86	+630.46%
May, 2029	$5.89	$6.07	$6.00	+569.42%
June, 2029	$5.86	$6.10	$5.80	+566.33%
July, 2029	$5.83	$5.78	$5.60	+562.46%
August, 2029	$5.04	$5.39	$5.64	+473.01%
September, 2029	$4.92	$4.92	$4.90	+458.56%
October, 2029	$4.84	$4.87	$4.97	+450.15%
November, 2029	$3.56	$3.84	$4.51	+305.03%
December, 2029	$3.17	$3.34	$3.43	+260.26%

Novabridge Biosciences Adr Stock (NBP) Price Forecast for 2030

Novabridge Biosciences Adr Stock (NBP) is expected to reach an average price of $7.26 in 2030, with a high forecast of $10.93 and a low forecast of $1.56. This signifies an +724.82% surge from the last price of $0.8801.

Month	Average	Low	High	Change from today's price
January, 2030	$2.47	$2.49	$2.79	+181.04%
February, 2030	$2.29	$2.26	$2.30	+159.76%
March, 2030	$1.78	$1.78	$2.10	+102.13%
April, 2030	$11.55	$1.56	$10.74	+1,212%
May, 2030	$10.53	$11.11	$10.93	+1,097%
June, 2030	$9.90	$9.95	$10.31	+1,025%
July, 2030	$9.52	$9.33	$9.31	+982.04%
August, 2030	$8.72	$8.97	$8.88	+890.42%
September, 2030	$8.49	$8.72	$8.39	+864.82%
October, 2030	$7.67	$7.68	$8.04	+770.93%
November, 2030	$7.46	$7.34	$7.24	+747.49%
December, 2030	$6.73	$6.77	$7.24	+665.07%

Similar to NBP